Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT02698111 · TERMINATED
Trial details
- NCT number
- NCT02698111
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-08
- Primary completion
- 2021-10-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.